This approval is based on the results of JETALS (The Japan Early-Stage Trial of Ultrahigh-Dose Methylcobalamin for ALS), multicenter, placebo-controlled, double-blind, randomized Phase III clinical trial in 130 patients with ALS, that was conducted as an investigator-initiated trial by a research team with Extraordinary Professor Ryuji Kaji (Principal Investigator), Tokushima University, and Professor Yuishin Izumi (Coordinating Investigator), the Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, and Professor Satoshi Kuwabara (Coordinating Investigator), the Department of Neurology, Chiba University Graduate School of Medicine
Great quality, great prices Deep Patel Reviewed on 01-09-2023 (5/5) Nice discount and best quality medicine generic ..thank you Mihir Ujjaniya Reviewed on 29-12-2023 (4/5) TORRENT PHARMACEUTICALS LIMITED Country of Origin - India Issue with Content
M.KauwellG
We go beyond hair care
Research suggests modest benefits for memory and processing speed, particularly in older adults